Publication

Lateralization of mesial temporal lobe epilepsy with chronic ambulatory electrocorticography

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    David King-Stephens, Pacific Medical CenterEmily Mirro, NeuroPace, Inc.Peter B Weber, Pacific Medical CenterKenneth D Laxer, Pacific Medical CenterPaul C Van Ness, University of Texas Southwestern Medical CenterVicenta Salanova, Indiana UniversityDavid C Spencer, Oregon Health and Science UniversityChristianne N Heck, University of Southern CaliforniaAlica Goldman, Baylor College of MedicineBarbara Jobst, Dartmouth-HitchcockDonald C Shields, George Washington UniversityGregory K Bergey, Johns Hopkins UniversityStephan Eisenschenk, University of FloridaGregory A Worrell, Mayo ClinicMarvin A Rossi, Rush Epilepsy CenterRobert Gross, Emory UniversityAndrew J Cole, Massachusetts General HospitalMichael R Sperling, Thomas Jefferson UniversityDileep R Nair, Cleveland ClinicRyder P Gwinn, Swedish Neuroscience InstituteYong D Park, Georgia Regents UniversityPaul A Rutecki, University of WisconsinNathan B Fountain, University of VirginiaRobert E Wharen, Mayo Clinic JacksonvilleLawrence J Hirsch, Yale UniversityIan O Miller, Miami Children’s HospitalGregory L Barkley, Henry Ford HospitalJonathan C Edwards, Medical University of South CarolinaEric B Geller, Saint Barnabas Medical CenterMichel J Berg, University of RochesterToni L Sadler, Via Christi HealthFelice T Sun, NeuroPace, Inc.Martha J Morrell, Stanford University
Language
  • English
Date
  • 2015-06-01
Publisher
  • Wiley
Publication Version
Copyright Statement
  • © 2015 Neuropace, Inc. Epilepsia published by Wiley Periodicals on behalf of International League Against Epilepsy.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0013-9580
Volume
  • 56
Issue
  • 6
Start Page
  • 959
End Page
  • 967
Supplemental Material (URL)
Abstract
  • Objective: Patients with suspected mesial temporal lobe (MTL) epilepsy typically undergo inpatient video-electroencephalography (EEG) monitoring with scalp and/or intracranial electrodes for 1 to 2 weeks to localize and lateralize the seizure focus or foci. Chronic ambulatory electrocorticography (ECoG) in patients with MTL epilepsy may provide additional information about seizure lateralization. This analysis describes data obtained from chronic ambulatory ECoG in patients with suspected bilateral MTL epilepsy in order to assess the time required to determine the seizure lateralization and whether this information could influence treatment decisions. Methods: Ambulatory ECoG was reviewed in patients with suspected bilateral MTL epilepsy who were among a larger cohort with intractable epilepsy participating in a randomized controlled trial of responsive neurostimulation. Subjects were implanted with bilateral MTL leads and a cranially implanted neurostimulator programmed to detect abnormal interictal and ictal ECoG activity. ECoG data stored by the neurostimulator were reviewed to determine the lateralization of electrographic seizures and the interval of time until independent bilateral MTL electrographic seizures were recorded. Results: Eighty-two subjects were implanted with bilateral MTL leads and followed for 4.7 years on average (median 4.9 years). Independent bilateral MTL electrographic seizures were recorded in 84%. The average time to record bilateral electrographic seizures in the ambulatory setting was 41.6 days (median 13 days, range 0-376 days). Sixteen percent had only unilateral electrographic seizures after an average of 4.6 years of recording. Significance: About one third of the subjects implanted with bilateral MTL electrodes required >1 month of chronic ambulatory ECoG before the first contralateral MTL electrographic seizure was recorded. Some patients with suspected bilateral MTL seizures had only unilateral electrographic seizures. Chronic ambulatory ECoG in patients with suspected bilateral MTL seizures provides data in a naturalistic setting, may complement data from inpatient video-EEG monitoring, and can contribute to treatment decisions.
Author Notes
  • Address correspondence to Martha J. Morrell, NeuroPace, Inc., 455 N. Bernardo Ave, Mountain View, CA 94043, U.S.A. E-mail: mmorrell@neuropace.com
Keywords
Research Categories
  • Biology, Neuroscience
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items